Brewin Dolphin LTD Guardant Health, Inc. Transaction History

Brewin Dolphin LTD

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Nov 09, 2023	BUY	$109.77 - $165.68 $1,097 - $1,656	10 Added 100.0%	20 $2.48 Million
Q1 2021 Nov 09, 2023	SELL	$127.04 - $179.1 $63,520 - $89,550	-500 Reduced 98.04%	10 $1.53 Million
Q4 2020 Nov 09, 2023	BUY	$99.96 - $135.93 $24,990 - $33,982	250 Added 96.15%	510 $65.7 Million
Q1 2020 Nov 09, 2023	BUY	$59.04 - $88.81 $590 - $888	10 Added 4.0%	260 $18.1 Million
Q3 2019 Nov 09, 2023	BUY	$62.59 - $110.3 $15,647 - $27,575	250 New	250 $16 Million

324

127M

844K

2.38M

Ticker GH
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 102,220,000
Market Cap $3.59B
Description
Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a cl...

Get notified when there are updates to the investment portfolio of Brewin Dolphin LTD, based on Form 13F filings with the SEC.

Stay updated on Brewin Dolphin LTD with notifications on news.